Dowling-Meara Epidermolysis Bullosa SimplexSymptoms, Doctors, Treatments, Advances & More
Dowling-Meara Epidermolysis Bullosa Simplex Overview
Learn About Dowling-Meara Epidermolysis Bullosa Simplex
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Joyce Teng is a Dermatologist and a Pediatrics provider practicing medicine in Palo Alto, California. Dr. Teng is rated as an Elite provider by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. She is also highly rated in 138 other conditions, according to our data. Her clinical expertise encompasses Lamellar Ichthyosis, Nonbullous Congenital Ichthyosiform Erythroderma, Nevoid Basal Cell Carcinoma Syndrome, Dowling-Meara Epidermolysis Bullosa Simplex, and Liver Embolization.
Dermatologists Of Southwest Ohio, Inc.
Anne Lucky is a Dermatologist practicing medicine in Cincinnati, Ohio. Dr. Lucky is rated as an Elite provider by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Dystrophic Epidermolysis Bullosa, Epidermolysis Bullosa, Dowling-Meara Epidermolysis Bullosa Simplex, and Dominant Dystrophic Epidermolysis Bullosa. Dr. Lucky is board certified in American Board Of Dermatology and American Board Of Pediatrics. Dr. Lucky is currently accepting new patients.
Catherine Laprise practices practicing medicine in Saguenay, Canada. Ms. Laprise is rated as an Elite expert by MediFind in the treatment of Dowling-Meara Epidermolysis Bullosa Simplex. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Dowling-Meara Epidermolysis Bullosa Simplex, Dominant Dystrophic Epidermolysis Bullosa, Asthma, and Epidermolysis Bullosa.
Summary: The proposed Phase 2/3 trial with double-blind and open-label extension phases is an international, multicenter study designed to assess the efficacy and safety of diacerein 1% ointment in patients with generalized EBS.
Summary: This Phase II clinical study will assess the efficacy, safety and tolerability of topical TolaSure Gel in adults and pediatric patients (4 years of age and older) diagnosed with generalized intermediate to severe epidermolysis bullosa simplex (EBS). Each patient (40 to complete) will be enrolled in the study and will be randomized to receive either TolaSure Gel or a topical Placebo for daily appli...